Clinical trial

JDQ443 for KRAS G12C NSCLC Brain Metastases

NCT05999357

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2024-04-15

PhasePHASE2

Study timeline

Study start (estimated)2024-04-15Date precision: day

Registry last updated2024-05-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancer Metastaticunresolved

Brain Metastases, Adultunresolved

KRAS G12Cunresolved

Interventions

JDQ443DRUG

Sponsors & collaborators

Maastricht University Medical Centerlead sponsor

Novartiscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05999357 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.